BR112022015461A2 - Polipeptídeos, ácido nucleico, vetor, célula hospedeira, proteínas de base do penton de adenovírus, complexo pentamérico, partícula semelhante a vírus (vlp), composição farmacêutica, métodos para produzir a vlp e para a produção de um polipeptídeo e método de identificação de uma sequência de ligação - Google Patents

Polipeptídeos, ácido nucleico, vetor, célula hospedeira, proteínas de base do penton de adenovírus, complexo pentamérico, partícula semelhante a vírus (vlp), composição farmacêutica, métodos para produzir a vlp e para a produção de um polipeptídeo e método de identificação de uma sequência de ligação

Info

Publication number
BR112022015461A2
BR112022015461A2 BR112022015461A BR112022015461A BR112022015461A2 BR 112022015461 A2 BR112022015461 A2 BR 112022015461A2 BR 112022015461 A BR112022015461 A BR 112022015461A BR 112022015461 A BR112022015461 A BR 112022015461A BR 112022015461 A2 BR112022015461 A2 BR 112022015461A2
Authority
BR
Brazil
Prior art keywords
vlp
polypeptide
adenovirus
polypeptides
virus
Prior art date
Application number
BR112022015461A
Other languages
English (en)
Portuguese (pt)
Inventor
Garzoni Frédéric
Original Assignee
Imophoron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imophoron Ltd filed Critical Imophoron Ltd
Publication of BR112022015461A2 publication Critical patent/BR112022015461A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1055Protein x Protein interaction, e.g. two hybrid selection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10323Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10333Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112022015461A 2020-02-05 2021-02-05 Polipeptídeos, ácido nucleico, vetor, célula hospedeira, proteínas de base do penton de adenovírus, complexo pentamérico, partícula semelhante a vírus (vlp), composição farmacêutica, métodos para produzir a vlp e para a produção de um polipeptídeo e método de identificação de uma sequência de ligação BR112022015461A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20155742 2020-02-05
EP20155982 2020-02-06
PCT/EP2021/052884 WO2021156489A1 (en) 2020-02-05 2021-02-05 Engineered polypeptides derived from variable domain of adenovirus penton base

Publications (1)

Publication Number Publication Date
BR112022015461A2 true BR112022015461A2 (pt) 2022-10-11

Family

ID=74561908

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022015461A BR112022015461A2 (pt) 2020-02-05 2021-02-05 Polipeptídeos, ácido nucleico, vetor, célula hospedeira, proteínas de base do penton de adenovírus, complexo pentamérico, partícula semelhante a vírus (vlp), composição farmacêutica, métodos para produzir a vlp e para a produção de um polipeptídeo e método de identificação de uma sequência de ligação

Country Status (10)

Country Link
US (1) US20230101439A1 (https=)
EP (1) EP4100421A1 (https=)
JP (1) JP2023513512A (https=)
CN (1) CN115427431A (https=)
AU (1) AU2021216124A1 (https=)
BR (1) BR112022015461A2 (https=)
CA (1) CA3166852A1 (https=)
MX (1) MX2022009574A (https=)
WO (1) WO2021156489A1 (https=)
ZA (1) ZA202209759B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024042100A1 (en) 2022-08-22 2024-02-29 Imophoron Limited Adenovirus penton-based virus-like particles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4597188B2 (ja) 2004-03-09 2010-12-15 アイトゲネシシェ・テヒニーシェ・ホッホシューレ・チューリッヒ 多タンパク質適用のための新規発現ツール
JP2012519476A (ja) 2009-03-06 2012-08-30 ヨーロピアン モレキュラー バイオロジー ラボラトリー 多タンパク質複合体のクローニング及び発現のための核酸
PL222497B1 (pl) * 2009-06-26 2016-08-31 Inst Biochemii I Biofizyki Pan Wektorowa cząsteczka wirusopodobna, sposób jej wytwarzania, kompozycja farmaceutyczna oraz zastosowanie wektorowej cząsteczki wirusopodobnej
EP3436591B1 (en) 2016-03-31 2023-01-04 The European Molecular Biology Laboratory Adenoviral coat protein derived delivery vehicles
WO2019016756A1 (en) * 2017-07-21 2019-01-24 Glaxosmithkline Biologicals Sa ANTIGEN CONSTRUCTS OF CHIKUNGUNYA VIRUSES
SG11202100898UA (en) * 2018-07-31 2021-02-25 Imophoron Ltd Multimerizing polypeptides derived from jelly roll fold domain of adenovirus penton base

Also Published As

Publication number Publication date
US20230101439A1 (en) 2023-03-30
WO2021156489A1 (en) 2021-08-12
CN115427431A (zh) 2022-12-02
ZA202209759B (en) 2023-07-26
EP4100421A1 (en) 2022-12-14
AU2021216124A1 (en) 2022-09-29
MX2022009574A (es) 2022-11-16
CA3166852A1 (en) 2021-08-12
JP2023513512A (ja) 2023-03-31

Similar Documents

Publication Publication Date Title
Llorca et al. Eukaryotic chaperonin CCT stabilizes actin and tubulin folding intermediates in open quasi‐native conformations
Boudko et al. The crucial role of trimerization domains in collagen folding
Bond et al. Coarse-grained molecular dynamics simulations of the energetics of helix insertion into a lipid bilayer
Franzot et al. The crystal structure of the actin binding domain from α-actinin in its closed conformation: structural insight into phospholipid regulation of α-actinin
Kunji et al. The mitochondrial ADP/ATP carrier exists and functions as a monomer
Luo et al. Self‐organization of a chiral D‐EAK16 designer peptide into a 3D nanofiber scaffold
US8969521B2 (en) General method for designing self-assembling protein nanomaterials
Abu-Baker et al. Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study
BR112022015461A2 (pt) Polipeptídeos, ácido nucleico, vetor, célula hospedeira, proteínas de base do penton de adenovírus, complexo pentamérico, partícula semelhante a vírus (vlp), composição farmacêutica, métodos para produzir a vlp e para a produção de um polipeptídeo e método de identificação de uma sequência de ligação
Dinjaski et al. Integrated modeling and experimental approaches to control silica modification of design silk-based biomaterials
Pinotsis et al. Evidence for a dimeric assembly of two titin/telethonin complexes induced by the telethonin C-terminus
Verdone et al. The solution structure of EMILIN1 globular C1q domain reveals a disordered insertion necessary for interaction with the α4β1 integrin
Reißer et al. Best of two worlds? How MD simulations of amphiphilic helical peptides in membranes can complement data from oriented solid-state NMR
Kjaergaard et al. Solution structure of recombinant somatomedin B domain from vitronectin produced in Pichia pastoris
Kairys et al. Structural model for an AxxxG‐mediated dimer of surfactant‐associated protein C
Calero-Rubio et al. Predicting unfolding thermodynamics and stable intermediates for alanine-rich helical peptides with the aid of coarse-grained molecular simulation
Campos et al. Modeling pilus structures from sparse data
Nowitzke et al. Mechanical unfolding of network nodes drives the stress response of protein-based materials
Khew et al. Template-assembled triple-helical peptide molecules: mimicry of collagen by molecular architecture and integrin-specific cell adhesion
Qu et al. Engineered design of the E-helix structure on ferritin nanoparticles
Sokolova Structure of cation channels, revealed by single particle electron microscopy
Poluri et al. World of proteins: Structure-function relationships and engineering techniques
Haspel et al. A protocol for the design of protein and peptide nanostructure self-assemblies exploiting synthetic amino acids
Arkin et al. How conformational transition depends on hydrophobicity of elastin-like polypeptides
Hartgerink Advancing Collagen Mimicry: Covalent Triple Helix Stabilization and Higher-order Nanostructure Design

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2865 DE 02-12-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.